Drug Discovery & Pharmaceuticals

RSS

Integrating physicochemical laws into future AI models for better drug design

Proteins play a key role not only in the body, but also in medicine: they either serve as active ingredients, such as enzymes or antibodies, or they are target structures for drugs.

30 Oct 2025

Merck partners with Promega to advance 3-D cell dug discovery technologies

Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to co-develop novel technologies that advance drug screening and discovery.

From Merck 30 Oct 2025

AI indelibly transforms solid tumor drug development

Artificial intelligence (AI) is fundamentally reshaping the landscape of solid tumor (ST) drug development.

29 Oct 2025

Harnessing bioinformatics to fast-track the discovery of spinal cord injury drug

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with no effective treatments.

29 Oct 2025

Experimental compound reduces cell death, inflammation, and organ damage in diabetes

An experimental compound reduced the cell death, inflammation, and organ damage seen with diabetes.

29 Oct 2025

Research shows the potential of structural nanomedicine in cancer treatment

In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic.

29 Oct 2025

Novel antibiotic shows activity against WHO high priority pathogen VRE

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE.

27 Oct 2025

GemPharmatech collaborates with MSK Cancer Center to accelerate discovery of therapeutic antibodies

GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies.

23 Oct 2025

Antibody discovery could provide new treatment options for aggressive breast cancers

A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.

23 Oct 2025

Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a promising broad-spectrum coronavirus antiviral pre-clinical candidate.

23 Oct 2025

Cyclana Bio raises £5M to advance drug discovery for endometriosis

Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women's health, today announced the close of a £5M pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, Wilbe, and Angel investors.

21 Oct 2025

VICT3R project builds momentum to accelerate animal-free safety testing

The VICT3R project is expanding its consortium by adding new beneficiaries and organisations to the network of contract research organisations (CROs) associated with the project.

16 Oct 2025

LassoESM accelerates discovery of therapeutic peptides

In the hunt for new therapeutics for cancer and infectious diseases, lasso peptides prove to be a catch.

16 Oct 2025

Machine learning advances drug discovery through generalizable models

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages is important for reducing cost and accelerating the path to clinical trials.

16 Oct 2025

New enzyme offers cleaner route to more stable diabetes and obesity drugs

Chemistry researchers at the University of Utah have uncovered an enzyme, dubbed PapB, that can "tie off" therapeutic peptides-protein-like drugs-into tight rings, a process known as macrocyclization.

16 Oct 2025

Caraway seeds inspire new seizure-fighting medicines

A UNLV-led team of researchers has co-opted a common kitchen spice to create a new class of cannabidiol (CBD)-like medicines that show powerful seizure-reducing effects - offering a safer, more affordable, and more effective treatment for childhood seizure disorders than existing frontline therapies.

15 Oct 2025

Drug Discovery & Pharmaceuticals

Integrating physicochemical laws into future AI models for better drug design

Merck partners with Promega to advance 3-D cell dug discovery technologies

AI indelibly transforms solid tumor drug development

Harnessing bioinformatics to fast-track the discovery of spinal cord injury drug

Experimental compound reduces cell death, inflammation, and organ damage in diabetes

Research shows the potential of structural nanomedicine in cancer treatment

Novel antibiotic shows activity against WHO high priority pathogen VRE

GemPharmatech collaborates with MSK Cancer Center to accelerate discovery of therapeutic antibodies

Antibody discovery could provide new treatment options for aggressive breast cancers

Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

Cyclana Bio raises £5M to advance drug discovery for endometriosis

VICT3R project builds momentum to accelerate animal-free safety testing

LassoESM accelerates discovery of therapeutic peptides

Machine learning advances drug discovery through generalizable models

New enzyme offers cleaner route to more stable diabetes and obesity drugs

Caraway seeds inspire new seizure-fighting medicines

CN Bio launches all-in-one Organ-on-a-chip system

New antimicrobial compounds offer safer solution for bovine mastitis

AI, omics, and systems biology could transform heart drug development

Breakthrough in RNA-targeted drug discovery offers hope against viral diseases

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest Life Science News